Tenaya Therapeutics (TNYA) Change in Account Payables (2020 - 2026)
Tenaya Therapeutics' (TNYA) quarterly Change in Account Payables came in at -$1.5 million in Q1 2026, down 285.22% year-on-year from $788233.6 in Q1 2025, and down 374.95% quarter-over-quarter from $531000.0 in Q4 2025.
Tenaya Therapeutics (TNYA) Change in Account Payables (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Change in Account Payables history runs 7 years deep, the most recent figure standing at -$1.5 million for Q1 2026.
- On a quarterly basis, Change in Account Payables fell 285.22% year-over-year to -$1.5 million in Q1 2026; TTM through Mar 2026 was -$2.5 million, a 12.5% decrease from a year earlier, with the FY2025 full-year figure at -$1.4 million, down 146.13% from the prior year.
- Change in Account Payables fell to -$1.5 million in Q1 2026 per TNYA's latest filing, from $531000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $3.5 million in Q4 2022 and bottomed at -$2.8 million in Q3 2023.
- The 5-year median for Change in Account Payables is -$379000.0 (2025), against an average of -$299588.2.
- Biggest YoY gain for Change in Account Payables was 422.87% in 2023; the steepest drop was 968.77% in 2023.
- Year by year, Change in Account Payables stood at $3.5 million in 2022, then plunged by 108.81% to -$305000.0 in 2023, then plunged by 129.84% to -$701000.0 in 2024, then jumped by 175.75% to $531000.0 in 2025, then slumped by 374.95% to -$1.5 million in 2026.
- Per Business Quant, the three latest TNYA Change in Account Payables figures stand at -$1.5 million (Q1 2026), $531000.0 (Q4 2025), and -$447000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Tenaya Therapeutics | 167.00 Mn | 167.00 Mn | - | -1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.46 Mn |
| Mar 31, 2026 | -1.46 Mn |
| Dec 31, 2025 | 531,000.00 |
| Dec 31, 2025 | 531,000.00 |
| Sep 30, 2025 | -447,000.00 |
| Sep 30, 2025 | -447,000.00 |
| Jun 30, 2025 | -1.14 Mn |
| Jun 30, 2025 | -1.14 Mn |
| Mar 31, 2025 | -379,000.00 |
| Mar 31, 2025 | -379,000.00 |
| Dec 31, 2024 | -701,000.00 |
| Dec 31, 2024 | -701,000.00 |
| Sep 30, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | -2.43 Mn |
| Jun 30, 2024 | -2.43 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | -305,000.00 |
| Dec 31, 2023 | -305,000.00 |